July 23 (Reuters) - Radiopharm Theranostics Ltd (RAD) :
- FDA IND APPROVAL FOR PHASE 2B TRIAL IN BRAIN METASTASES
(([email protected];))
- Forums
- ASX - By Stock
- News: RAD Radiopharm Theranostics Receives FDA Ind Approval For Phase 2B Trial In Brain Metastases
July 23 (Reuters) - Radiopharm Theranostics Ltd (RAD) : FDA IND...
Add RAD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.001(1.49%) |
Mkt cap ! $65.60M |
Open | High | Low | Value | Volume |
3.3¢ | 3.4¢ | 3.2¢ | $2.212M | 66.06M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 392260 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 1832841 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 331957 | 0.033 |
4 | 143119 | 0.032 |
6 | 442255 | 0.031 |
11 | 1009783 | 0.030 |
3 | 225749 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 1832841 | 2 |
0.036 | 69131 | 1 |
0.037 | 200000 | 1 |
0.038 | 230456 | 3 |
0.039 | 406637 | 3 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
RAD (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online